510(k) K013568

CEA ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM by Bayer Corp. — Product Code DHX

K013568 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "CEA ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM". The FDA issued a decision of Substantially Equivalent on December 21, 2001. The device falls under product code DHX (System, Test, Carcinoembryonic Antigen), a Class II device regulated under 21 CFR 866.6010. Bayer Corp. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 21, 2001
Date Received
October 26, 2001
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Test, Carcinoembryonic Antigen
Device Class
Class II
Regulation Number
866.6010
Review Panel
IM
Submission Type